TD Cowen Reiterates Buy Rating on Novo Nordisk (NVO) Following Monlunabant Obesity Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/13/2026

1. CSCO
2. CBRS
3. COHR
4. SPY
5. BTGO
6. NVDA
7. WYFI
8. STUB
9. EAT
10. GO

Go back to TD Cowen Reiterates Buy Rating on Novo Nordisk (NVO) Following Monlunabant Obesity Update
NOVO-NORDISK A/S (NYSE: NVO) Delayed: 46.72 +0.33 (0.71%)
Previous Close $46.39    52 Week High $59.00 
Open $45.96    52 Week Low $32.80 
Day High $46.79    P/E N/A 
Day Low $45.73    EPS $0.00 
Volume 10,186,211